Europe Bio Pharmaceuticals market by Product Type (Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH)) by Therapeutic Type (Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Bio Pharmaceuticals market by Product Type (Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH)) by Therapeutic Type (Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 635 | Pages: 143 | October 2016 | Region: Europe


The Europe Bio Pharmaceuticals market was worth $37.12 billion in 2016 and estimated to be growing at a CAGR of 8.89%, to reach $56.83 billion by 2021. Europe is the second largest market for biopharmaceuticals globally. 

Development of biopharmaceutical product is being undertaken by increasing number of competitors in the pharmaceutical industry. Market players are more focusing on expanding the biologics pipeline, relying on the fact that commercialization of biopharmaceuticals will reduce the usage of traditional small molecular drugs. Pharmaceutical industries mainly rely on biopharmaceuticals for profits and innovation.

Advancement in biomedical science holds vast potential for the growth of biopharmaceuticals market. Ability of these drugs to treat chronic diseases which were earlier untreatable is increasing its demand enormously and also increases the profit margin for manufacturers. Biopharmaceutical drugs need to be stored in cold storage which limits their transport to rural areas and hence hindering the growth of the market.

The Europe bio pharmaceuticals market is segmented on the basis of products into Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH). Monoclonal antibodies segment holds the highest number of shares in the product sector. Based on therapeutics, the market is bifurcated into Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and other therapeutic areas. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market.

Based on geography the market is analysed under various regions namely, Germany, Italy, France, U.K and Spain. In Europe, Germany, France and the U.K. covers the major share of biopharmaceutical market.

Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc., and Novartis AG are some of the leading players in the market for biopharmaceuticals.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies (mAb)       

                                5.1.2 Erythropoietin       

                                5.1.3 Biotech Vaccines  

                                5.1.4 Recombinant Human (RH) Insulin 

                                5.1.5 Granulocyte colony-stimulating factor (G-CSF)       

                                5.1.6 Interferon               

                                5.1.7 Human growth hormones (HGH)  

                5.2 By Therapeutic Type                               

                                5.2.1 Neurology               

                                5.2.2 Infectious diseases              

                                5.2.3 Diabetes  

                                5.2.4 Oncology 

                                5.2.5 Cardiovascular       

                                5.2.6 Other Therapeutic Areas  

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 U.K 

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Merck & Co.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 F. Hoffmann-La Roche AG                    

                8.3 Eli Lilly and Company                              

                8.4 Sanofi                           

                8.5 Amgen Inc.                 

                8.6 AbbVie Inc.                 

                8.7 Biogen Idec                

                8.8 Bayer AG                     

                8.9 Johnson & Johnson Services                               

                8.10 Pfizer                          

                8.11 Novartis AG                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Bio Pharmaceuticals Market By Region, From 2016-2021 (USD Billion)
  2. Europe Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  3. Europe Monoclonal Antibodies (mAb) Market By Region, From 2016-2021 (USD Billion)
  4. Europe Erythropoietin Market By Region, From 2016-2021 (USD Billion)
  5. Europe Biotech Vaccines Market By Region, From 2016-2021 (USD Billion)
  6. Europe Recombinant Human (RH) Insulin Market By Region, From 2016-2021 (USD Billion)
  7. Europe Granulocyte colony-stimulating factor (G-CSF) Market By Region, From 2016-2021 (USD Billion)
  8. Europe Interferon Market By Region, From 2016-2021 (USD Billion)
  9. Europe Human growth hormones (HGH) Market By Region, From 2016-2021 (USD Billion)
  10. Europe Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  11. Europe Neurology Market By Region, From 2016-2021 (USD Billion)
  12. Europe Infectious diseases Market By Region, From 2016-2021 (USD Billion)
  13. Europe Diabetes Market By Region, From 2016-2021 (USD Billion)
  14. Europe Oncology Market By Region, From 2016-2021 (USD Billion)
  15. Europe Cardiovascular Market By Region, From 2016-2021 (USD Billion)
  16. Europe Other Therapeutic Areas Market By Region, From 2016-2021 (USD Billion)
  17. U.K Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  18. U.K Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  19. Spain Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  20. Spain Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  21. Germany Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  22. Germany Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  23. Italy Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  24. Italy Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  25. France Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  26. France Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
Middle East And Africa Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & ...
Latin America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Asia Pacific Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnol...
Europe Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Co...
North America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies...
Middle East And Africa Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics),...
Latin America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Asia Pacific Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User ...
Europe Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospi...
North America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospital, Cl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.